Sanofi-Aventis S.A. ADR (SNY)

Feb 22, 2025, 2:30 AM EST - 15 hours ago

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's disease

Feb 19, 2025, 7:19 AM EST - 3 days ago

Sanofi: OpenAI's Research Agents Could Lead To Explosive Growth

Feb 19, 2025, 1:30 AM EST - 3 days ago

Press Release: Sanofi and CD&R sign Opella share purchase agreement

Feb 13, 2025, 2:09 PM EST - 9 days ago

Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial Report

Feb 13, 2025, 1:00 AM EST - 9 days ago

Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

Feb 7, 2025, 1:13 AM EST - 15 days ago

Healthcare company Sanofi announces share buyback of up to 2 billion euros

Feb 7, 2025, 1:00 AM EST - 15 days ago

Press Release: Execution of a share buyback agreement for up to €2 billion

Feb 4, 2025, 5:30 AM EST - 18 days ago

MITEM PHARMA Continues Its Mission to Protect the Interests of Patients Suffering From Rare and Lethal Diseases by Acquiring the FLISINT® Speciality from SANOFI

Feb 3, 2025, 1:30 AM EST - 19 days ago

Agreement Between L'Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L'Oréal

Feb 3, 2025, 1:30 AM EST - 19 days ago

Press Release: Sanofi announces buy back of shares from L'Oréal

Jan 31, 2025, 1:00 AM EST - 22 days ago

Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

Jan 30, 2025, 2:41 PM EST - 23 days ago

Sanofi (SNY) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 10:30 AM EST - 23 days ago

Sanofi CEO Paul Hudson on RFK Jr.'s vaccine stance

Jan 30, 2025, 7:15 AM EST - 23 days ago

Sanofi CEO Paul Hudson on Q4 results: We've set ourselves up very well for 2025

Jan 30, 2025, 1:33 AM EST - 23 days ago

Sanofi meets estimates for fourth-quarter profit, plans 5 billion euros in buybacks

Jan 23, 2025, 1:00 PM EST - 4 weeks ago

'The next battleground': Sanofi exploring opportunities in second generation obesity drugs

Jan 22, 2025, 1:00 AM EST - 4 weeks ago

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Jan 21, 2025, 1:00 AM EST - 4 weeks ago

Press Release: Opella reaches study milestone for Cialis

Jan 19, 2025, 4:54 PM EST - 4 weeks ago

Top 4 Immunology Stocks Poised For Growth In 2025

ABBV BMY TEVA

Jan 14, 2025, 3:30 PM EST - 5 weeks ago

Sanofi (SYN) CEO Paul Hudson Hosts 43rd Annual J.P. Morgan Healthcare (Transcript)

Jan 13, 2025, 6:10 PM EST - 5 weeks ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Jan 13, 2025, 9:00 AM EST - 5 weeks ago

Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi

Jan 13, 2025, 1:00 AM EST - 5 weeks ago

Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

Jan 10, 2025, 11:45 AM EST - 6 weeks ago

Sanofi: Underappreciated Powerhouse Primed For Long-Term Growth (Rating Upgrade)

Jan 9, 2025, 1:00 AM EST - 6 weeks ago

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Jan 7, 2025, 10:00 AM EST - 6 weeks ago

Alloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic™ Antisense Platform with Sanofi

Jan 2, 2025, 5:51 AM EST - 7 weeks ago

Gaming stocks likely to outperform semiconductor stocks in 2025

EA MSFT TTWO

Dec 31, 2024, 7:05 AM EST - 7 weeks ago

Drugmakers to raise US prices on over 250 medicines starting Jan. 1

BMY PFE

Dec 23, 2024, 1:00 AM EST - 2 months ago

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Dec 19, 2024, 12:00 PM EST - 2 months ago

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Dec 17, 2024, 2:25 PM EST - 2 months ago

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's

TEVA

Dec 17, 2024, 11:51 AM EST - 2 months ago

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

TEVA

Dec 17, 2024, 9:16 AM EST - 2 months ago

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

TEVA

Dec 17, 2024, 8:30 AM EST - 2 months ago

BrightInsight Expands Global Digital Partnership with Sanofi to Build Drug Companion Apps for its Major Specialty Therapies

Dec 17, 2024, 7:35 AM EST - 2 months ago

Teva, Sanofi say drug to treat IBD met primary targets

TEVA

Dec 17, 2024, 7:30 AM EST - 2 months ago

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn's disease

Dec 13, 2024, 1:00 AM EST - 2 months ago

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Dec 12, 2024, 5:54 PM EST - 2 months ago

Gilead appoints Sanofi official Dietmar Berger as next chief medical officer

GILD

Dec 11, 2024, 1:00 AM EST - 2 months ago

Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US

Dec 9, 2024, 2:06 PM EST - 2 months ago

Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients

Dec 7, 2024, 11:30 AM EST - 2 months ago

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP

Dec 6, 2024, 8:00 AM EST - 2 months ago

Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program

Dec 6, 2024, 1:30 AM EST - 2 months ago

Press Release: Availability of the revised financial statements for Sanofi excluding Opella

Dec 5, 2024, 12:49 AM EST - 2 months ago

Global Fortune 500 Company Doubles Down on Beijing E-Town with Back-to-Back Investments Over Three Years: Insights from the Sanofi Project into E-Town's Business Environment

Dec 4, 2024, 7:07 AM EST - 2 months ago

China's First International Pharma Biotherapeutic API Project Launched in Beijing E-Town -- Sanofi Invests Approximately 1 Billion Euros in New Insulin Production Facility

Dec 3, 2024, 12:41 AM EST - 2 months ago

Sanofi to Invest $1 Billion in New Insulin Manufacturing Base in China

Dec 2, 2024, 6:36 AM EST - 2 months ago

Sanofi to invest $1 bln in insulin production site in Beijing, local authority says

Nov 27, 2024, 2:56 AM EST - 3 months ago

Pharma giant Sanofi opens $595 million vaccine facility in Singapore to boost preparedness for potential pandemics

Nov 22, 2024, 12:32 PM EST - 3 months ago

Sanofi plans to change hospital drug-discount program, WSJ reports

Nov 18, 2024, 10:49 AM EST - 3 months ago

Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase